Abu dhabi: PureHealth Holding has released its financial results for the year ending December 31, 2025, and has proposed a cash dividend of AED600 million for FY 2025, pending regulatory and shareholder approvals.
According to Emirates News Agency, the group reported revenue of AED27.3 billion in FY2025, marking a 5.7 percent increase year-on-year, bolstered by strong performances in its Healthcare (Care) and Insurance (Cover) divisions.
EBITDA saw a 16.1 percent year-on-year rise to AED4.8 billion, driven by ongoing efficiency enhancements, synergies, and the contribution from the recent acquisition of Hellenic Healthcare Group (HHG) in Greece and Cyprus in Q4-2025. The Group's net profit increased by 17.7 percent year-on-year to AED2 billion, with pretax profits growing 26.1 percent year-on-year to AED2.2 billion.
This robust performance supports the proposal for a AED600 million dividend for FY 2025, representing approximately 30 percent of net profit, to be paid in two equal semiannual installments. The proposed dividend highlights PureHealth's strong balance sheet, stable earnings base, and consistent cash generation through market cycles.
The dividend framework reflects PureHealth's strategic expansion of its local and international platform, sustained financial performance, and disciplined capital allocation, as the Group continues its long-term growth strategy as a global healthcare entity. PureHealth operates across various regions including the UAE, USA, UK, Greece, and Cyprus, facilitated by rising patient volumes, expanded clinical capacity, specialized services, and continued investment in AI-enabled healthcare delivery.
Kamal Al Maazmi, Chairman of PureHealth, remarked on the significant progress made in 2025 toward establishing a global, technology-driven healthcare group. He emphasized the proposed dividend policy as a testament to the Board's confidence in PureHealth's financial strength and commitment to sustainable shareholder value while maintaining investment flexibility for long-term growth.
Farhan Malik, Founder and Managing Director of PureHealth, highlighted the strong financial performance and capital deployment strategy. He noted that the company's international business, with 50 percent of assets outside the UAE, allows for diversified revenue streams. This enables the rewarding of shareholders with a AED600 million dividend while investing in PureHealth's expansion.
Shaista Asif, Group CEO of PureHealth, commented on the 2025 results, underscoring the effectiveness of the Care and Cover model in generating resilient earnings and strong cash flow. Growth was seen across the UAE, the UK through Circle Health Group, and the acquisition of Hellenic Healthcare Group in Greece and Cyprus. The digital solutions and AI deployment are creating a unique platform positioning PureHealth ahead in AI-powered healthcare.
